6-(Chloromethyl)pteridine-2,4-diamine hydrochloride, 98%, 5g

4-BROMO-3-(BROMOMETHYL)BENZONITRILE, 95.0%, 250mg

5-phenyl-1-[4-(propan-2-yl)phenyl]-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 1g

ICP-MS-Mehrelementstandardlösung, 100 ml

3-(Difluoromethyl)pyridine (stabilised over Potassium Carbonate), 97.0%, 25g

5-Hexyl-[1,3]dithiolo[4,5-d][1,3]dithiole-2-thione, 97%, 1g

tert-Butyl (3S,4S)-3-amino-4-fluoropiperidine-1-carboxylate, 97%, 1g

4-(2-Methoxy-phenyl)-thiazol-2-ylamine, 95.0%, 5g

Butylamine>99.0%(GC)(T)25mL

Ethyl 2-(6-oxo-1,6-dihydropyridazin-3-yl)acetate, 97%, 250mg

tert-Butyl 4-(5-bromo-3-methylpyridin-2-yl)piperazine-1-carboxylate, 95.0%, 25g

Fluorescein-5-maleimide (contains 2% N,N-Dimethylformamide at maximum)>97.0%(HPLC)25mg

2,2-Dimethyl-3-(4-methyl-piperidin-1-yl)-propan-1-ol, 250mg